menu
    • menu

    Company profile for Sinovac Biotech

    NEW Drugs in Dev: 59
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac's product portfolio includes vaccines against enterovirus71 (EV71), hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), varicella vaccine and mumps. Healive, the hepat...
    Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac's product portfolio includes vaccines against enterovirus71 (EV71), hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), varicella vaccine and mumps. Healive, the hepatitis A vaccine manufactured by the Company, has passed the assessment under WHO prequalification procedures in 2017.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sinovac BiotechChina Flag
    Country
    Country
    China
    Address
    Address
    No.39, SHANGDI West Road, Haidian District, Beijing, P.R.C.
    Telephone
    Telephone
    +86-10-8289-0088
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.sinovac.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SINOVAC Reports Unaudited First Half Of 2025 Financial Results
    SINOVAC Reports Unaudited First Half Of 2025 Financial Results

    09 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7416244

    FIRSTWORD PHARMA
    09 May 2026
    Share Share
    SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
    SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing

    22 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260122376718/en/SINOVAC-Announces-Nasdaq-Hearings-Panel-Grants-Continued-Listing

    BUSINESSWIRE
    22 Jan 2026
    Share Share
    Sinovac Notified By Nasdaq For Late 2025 Half-Year Report
    Sinovac Notified By Nasdaq For Late 2025 Half-Year Report

    04 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260104600593/en/Sinovac-Receives-Nasdaq-Notification-Regarding-Late-Filing-of-2025-Half-Year-Report

    BUSINESSWIRE
    04 Jan 2026
    Share Share
    SINOVAC Updates Antigua High Court Order And Auditor Engagement
    SINOVAC Updates Antigua High Court Order And Auditor Engagement

    04 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260104122574/en/SINOVAC-Provides-Update-on-Antigua-High-Court-Order-and-Auditor-Engagement

    BUSINESSWIRE
    04 Jan 2026
    Share Share
    Sinovac Board Secures Interim Control Amid Shareholder Meeting
    Sinovac Board Secures Interim Control Amid Shareholder Meeting

    17 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217962502/en/Sinovac-Antigua-Court-Makes-Interim-Order-Giving-Board-Control-of-the-Company-until-the-Trial-of-the-Disputed-2025-Shareholder-Meeting

    BUSINESSWIRE
    17 Dec 2025
    Share Share
    Sinovac Receives Nasdaq Delisting Notice, Plans Appeal
    Sinovac Receives Nasdaq Delisting Notice, Plans Appeal

    18 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251118608375/en/SINOVAC-Announces-Receipt-of-Nasdaq-Notice-of-Delisting-and-Intention-to-Appeal

    BUSINESSWIRE
    18 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Contact Sinovac Biotech and get a quotation

    Sinovac Biotech is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find Captopril bulk offered by Sinovac Biotech

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search